WebIonis Pharmaceuticals, Inc. 32,746 followers on LinkedIn. For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care... Web11 apr. 2024 · In the last 3 months, 10 analysts have offered 12-month price targets for Ionis Pharmaceuticals. The company has an average price target of $46.1 with a high …
Mickael Rabilloud - Vice President Strategic Sourcing - LinkedIn
WebIonis Pharmaceuticals, Inc. 36,390 followers on LinkedIn. For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing … WebIonis Pharmaceuticals, Inc. 32,595 followers on LinkedIn. For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading … read baroness casey review
Associate Director - Ionis Pharmaceuticals, Inc. - LinkedIn
WebWork Biography for Bao Mai, Ionis Pharmaceuticals. Bao Mai works as a Analytical Chemist at Ionis Pharmaceuticals, which is a Pharmaceuticals company with an estimated 660 employees; and founded in 1989. Bao is currently based in Carlsbad, United States. Follow Bao Mai on LinkedIn, Twitter to get to know them better. Hmmm… Web11 apr. 2024 · En el último trimestre, Ionis Pharmaceuticals (NASDAQ: IONS) ha recibido las siguientes calificaciones por parte de los analistas: En los últimos 3 meses, 10 analistas le han asignado precios objetivo de 12 meses a Ionis Pharmaceuticals. La compañía tiene un precio objetivo promedio de 46,10 dólares, con un máximo de 67,00 dólares y un ... Web10 jan. 2016 · Astellas Pharma US. Sep 2024 - Present4 years 7 months. Global. I am in charge of Research, Development and Medical Affairs Procurement globally. I have team members located in Japan, EMEA and USA ... read barney